The susceptibility of the mammary gland to carcinogenesis is influenced by its normal development, particularly during developmental stages such as puberty and pregnancy that are characterized by marked changes in proliferation and differentiation. Protein kinases are important regulators of proliferation and differentiation, as well as of neoplastic transformation, in a wide array of tissues, including the breast. Using a RT-PCR-based cloning strategy, we have identified 41 protein kinases that are expressed in breast cancer cell lines and in the murine mammary gland during development. The expression of each of these kinases was analyzed throughout postnatal mammary gland development as well as in a panel of mammary epithelial cell lines derived from distinct transgenic models of breast cancer. Although the majority of protein kinases isolated in this screen have no currently recognized role in mammary development, most kinases examined were found to exhibit developmental regulation. After kinases were clustered on the basis of similarities in their temporal expression profiles during mammary development, multiple distinct patterns of expression were observed. Analysis of these patterns revealed an ordered set of expression profiles in which successive waves of kinase expression occur during development. Interestingly, several protein kinases whose expression has previously been reported to be restricted to tissues other than the mammary gland were isolated in this screen and found to be expressed in the mammary gland. In aggregate, these findings suggest that the array of kinases participating in the regulation of normal mammary development is considerably broader than currently appreciated.
INTRODUCTION
Numerous epidemiologic and animal studies analyzing the impact of reproductive events such as puberty, pregnancy, and parity on early events in carcinogenesis suggest that the developmental state of the breast plays a critical role in the determination of breast cancer risk (Lambe et al., 1994; MacMahon et al., 1970 MacMahon et al., , 1982 Newcomb et al., 1994; Russo, 1978, 1987) . This implies an intrinsic relationship between the process of carcinogenesis and normal pathways of differentiation and development in the breast. Therefore, understanding the mechanisms by which reproductive events influence breast cancer susceptibility will undoubtedly require an improved understanding of normal mammary development, particularly with respect to genes that control mammary proliferation and differentiation.
Protein kinases represent the largest class of genes known to regulate differentiation, development, and carcinogenesis in eukaryotes. Therefore, we have chosen to study members of this family of regulatory proteins as one approach to elucidating the relationship between development and carcinogenesis in the breast. Several protein kinases have been implicated in the development of breast cancer either in humans or in rodent model systems. For instance, the EGF receptor and ErbB2/HER2 are each amplified and overexpressed in subsets of highly aggressive breast cancers, and these molecules may thereby provide prognostic information relevant to clinical treatment and outcome (Klijn et al., 1993; Slamon et al., 1987 Slamon et al., , 1989 . Furthermore, overexpression of specific protein kinases, or 1 These authors contributed equally to this article. 2 To whom correspondence should be addressed. of ligands for protein kinases, in the mammary epithelium of transgenic animals results in neoplastic transformation (Cardiff and Muller, 1993; Guy et al., 1994; Muller et al., 1988 Muller et al., , 1990 . Finally, by analogy with hematopoiesis, some protein kinases are likely to be expressed in a lineagerestricted manner in the breast and as such may provide insight into biologically meaningful subpopulations of cells (Dymecki et al., 1990; Siliciano et al., 1992; Tsukada et al., 1993) . These findings suggest that further analysis of protein kinase function may reveal significant features of the relationship between development and carcinogenesis in the breast, as well as provide insight into how the decision to proliferate or differentiate is made in mammary epithelial cells.
In light of the importance of this class of regulatory molecules, we initiated a systematic study of the role of protein kinases in mammary gland development and carcinogenesis. Examination of 1450 cDNA clones generated using a RT-PCR-based screening strategy identified 41 protein kinases, including 33 tyrosine kinases and 8 serine/ threonine kinases, 3 of which were novel. The expression of these kinases was subsequently examined during defined stages in mammary development and in a panel of mammary tumor cell lines derived from distinct transgenic models of breast cancer. Our findings reveal an ordered series of protein kinase expression patterns that occur during each of the stages of postnatal mammary development, suggesting that these molecules may be important regulators of this process.
MATERIALS AND METHODS

Cell Culture
Mammary epithelial cell lines were derived from mammary tumors or hyperplastic lesions that arose in MMTV-c-myc, MMTV-int-2, MMTV-neu/NT, or MMTV-Ha-ras transgenic mice and included: the neu transgene-initiated mammary tumor-derived cell lines SMF, NAF, NF639, NF11005, and NK-2; the c-myc transgene-initiated mammary tumor-derived cell lines 16MB9a, 8Ma1a, MBp6, M158, and M1011; the Ha-ras transgene-initiated mammary tumor-derived cell lines AC816, AC236, and AC711; the int-2 transgene-initiated hyperplastic cell line HBI2; and the int-2 transgene-initiated mammary tumor-derived cell line 1128 (Morrison and Leder, 1994) . Additional cell lines were obtained from ATCC and included NIH3T3 cells and the nontransformed murine mammary epithelial cell lines NMuMG and CL-S1. All cells were cultured under identical conditions in DMEM medium supplemented with 10% bovine calf serum, 2 mM L-glutamine, 100 units/ml penicillin, and 100 mg/ml streptomycin.
Animals and Tissues
FVB mice were housed under barrier conditions with a 12-h light/dark cycle. The mammary glands from between 10 and 40 age-matched mice were pooled for each developmental point. Mice for pregnancy points were mated at 4 -5 weeks of age. Mammary gland harvest consisted in all cases of the No. 3, 4, and 5 mammary glands. The lymph node embedded in the No. 4 mammary gland was removed prior to harvest. Tissues used for RNA preparation were snap frozen on dry ice. Tissues used for in situ hybridization analysis were embedded in OCT medium and frozen in a dry ice/isopentane bath. Developmental expression patterns for 13 kinases were confirmed using independent pools of RNA. Analysis of the developmental expression pattern for an additional kinase using these independent pooled samples revealed a similar pregnancy-upregulated expression pattern that differed with respect to the day of pregnancy at which maximal upregulation occurred.
Construction and Analysis of Kinase-Specific cDNA Libraries
Kinase-specific cDNA libraries were constructed using mRNA prepared from the mammary glands of mice at specified stages of development and from a panel of mammary epithelial cell lines. Specifically, total RNA was prepared from the mammary glands of either 5-week-old nulliparous female mice or parous mice that had undergone a single pregnancy followed by 21 days of lactation and 2 days of postlactational regression. Total RNA was also prepared from the mammary epithelial cell lines NMuMG, CL-S1, HBI2, SMF, 16MB9a, AC816, and 1128, described above.
First-strand cDNA was generated from each of these nine sources of RNA using the cDNA Cycle kit according to the manufacturer's directions (Invitrogen). These were amplified using degenerate oligonucleotide primers corresponding to conserved regions in kinase catalytic subdomains VI and IX. The degenerate primers, PTKIa (5Ј-GGGCCCGGATCCAC(A/C)G(A/G/C/T)GA-(C/T)(C/T)-3Ј) and PTKIIa (5Ј-CCCGGGGAATTCCA(A/T)AGG-ACCA(G/C)AC(G/A)TC-3Ј), have previously been shown to amplify a conserved 200-bp portion of the catalytic domain of a wide variety of tyrosine kinases (Wilks, 1989 (Wilks, , 1991 Wilks et al., 1989) . Two additional degenerate oligonucleotide primers, BSTKIa (5Ј-GGGCCCGGATCC(G/A)T(A/G)CAC(A/C)G(A/G/C)GAC(C/T)T-3Ј) and BSTKIIa (5Ј-CCCGGGGAATTCC(A/G)(A/T)A(A/G)CTC-CA(G/C)ACATC-3Ј), that differed from PTKIa and PTKIIa were also designed for this study. Restriction sites, underlined in the primer sequences, were generated at the 5Ј (ApaI and BamHI) and 3Ј (XmaI and EcoRI) ends of the primer sequences.
Each cDNA source was amplified in three separate PCR reactions using pairwise combinations of the PTKIa/PTKIIa, BSTKIa/ BSTKIIa, or BSTKIa/PTKIIa degenerate primers. Following 5-min denaturation at 95°C, samples were annealed at 37°C for 1 min, polymerized at 63°C for 2 min, and denatured at 95°C for 30 s for 40 cycles. The resulting ϳ200-bp PCR products were purified from low-melting agarose (BMB), ligated into a T-vector (Invitrogen), and transformed in Escherichia coli. Following blue/white color selection, approximately 50 transformants were picked from each of the 27 PCR reactions (3 reactions for each of nine cDNA sources) and were subsequently transferred to gridded plates and replica plated. In total, 1450 transformants were analyzed.
Dideoxy sequencing of 100 independent transformants was performed, resulting in the identification of 14 previously described tyrosine kinases. In order to identify and eliminate additional isolates of these kinases from further consideration, filter lifts representing the 1350 remaining transformants were hybridized individually to radiolabeled DNA probes prepared from each of the 14 initially isolated kinases. Hybridization and washing were performed as described under final washing conditions of 0.1ϫ SSC/0.1% SDS at 70°C that were demonstrated to prevent crosshybridization between kinase cDNA inserts (Marquis et al., 1995) . In this manner, 887 transformants containing inserts from the 14 tyrosine kinases that had initially been isolated were identified.
Identifications made by colony hybridization were consistent with those made directly by DNA sequencing.
The remaining 463 transformants were screened by PCR using T7 and SP6 primers to identify those containing cDNA inserts of a length expected for protein kinases. One hundred seventy-two transformants were found to have cDNA inserts between 150 and 300 bp in length and were subjected to further analysis by successive rounds of dideoxy sequencing and colony lift hybridization. This resulted in the identification of 27 additional protein kinases.
Individual clones were sequenced using the Sequenase version 2 dideoxy chain termination kit (U.S. Biochemical Corp.). Putative protein kinases were identified by the DFG consensus located in catalytic subdomain VI. DNA sequence analysis was performed using MacVector 3.5 and the NCBI BLAST server.
RNA Preparation and Analysis
RNA was prepared by homogenization of snap-frozen tissue samples or tissue culture cells in guanidinium isothiocyanate supplemented with 7 l/ml 2-mercaptoethanol followed by ultracentrifugation through cesium chloride as previously described (Marquis et al., 1995; Rajan et al., 1997) . Poly(A) ϩ RNA was selected using oligo(dT) cellulose (Pharmacia), separated on a 1.0% LE agarose gel, and passively transferred to a Gene Screen membrane (NEN). Northern hybridization was performed as described using 32 P-labeled cDNA probes corresponding to catalytic subdomains VI-IX of each protein kinase that were generated by PCR amplification of cloned catalytic domain fragments (Marquis et al., 1995) . In all cases calculated transcript sizes were consistent with values reported in the literature.
In Situ Hybridization
In situ hybridization was performed as described (Marquis et al., 1995) . Antisense and sense probes were synthesized with the Promega in vitro transcription system using 35 S-UTP and 35 S-CTP from the T7 and SP6 RNA polymerase promoters of a PCR template containing the sequences used for Northern hybridization analysis.
RESULTS
Identification of Protein Kinases Expressed in the Murine Mammary Gland
As an initial step in studying the role of protein kinases in regulating mammary proliferation and differentiation, we designed a screen to identify protein kinases expressed in the mammary gland and in breast cancer cell lines. An RT-PCR cloning strategy was employed that relies on the use of degenerate oligonucleotide primers corresponding to conserved amino acid motifs present within the catalytic domain of protein tyrosine kinases (Wilks, 1989; Wilks et al., 1989) . RNA prepared from nine different sources was used as starting material for the generation of kinasespecific cDNA libraries. These sources included mammary glands from 5-week-old nulliparous mice undergoing puberty and parous mice at day 2 of involution, as well as a panel of seven murine mammary epithelial cell lines. Cell lines consisted of two nontransformed mammary epithelial cell lines in addition to five cell lines derived from tumors and hyperplasias that arose in the mammary glands of MMTV-neu, MMTV-c-myc, MMTV-Ha-ras, or MMTV-int2 transgenic mice (Leder et al., 1986; Muller et al., 1988 Muller et al., , 1990 Sinn et al., 1987) . Mammary tumors arising in each of these transgenic strains have previously been demonstrated to possess distinct and characteristic histopathologies that have been described as a large basophilic cell adenocarcinoma associated with the myc transgene, a small eosinophilic cell papillary carcinoma associated with the Ha-ras transgene, a pale intermediate cell nodular carcinoma associated with the neu transgene, and a papillary adenocarcinoma associated with the int-2 transgene (Cardiff and Muller, 1993; Cardiff et al., 1991; Munn et al., 1995) .
First-strand cDNA prepared from each of these sources was independently amplified using the previously described degenerate oligonucleotide primers, PTKI and PTKII, that encode conserved amino acid motifs within catalytic subdomains VIb and IX (Hanks and Quinn, 1991; Wilks, 1991; Wilks et al., 1989) . In an effort to isolate a broad array of protein kinases, two additional degenerate oligonucleotide primers, BSTKI and BSTKII, which are also directed against subdomains VIb and IX, but which differ in nucleotide sequence, were designed for use in this screen. Degenerate oligonucleotide primers were used in three pairwise combinations (PTKI/PTKII, BSTKI/BSTKII, and BSTKI/PTKII) to amplify first-strand cDNA from each of the nine sources. The resulting 150-to 300-bp PCR products from each amplification were subcloned into a plasmid vector. Approximately 50 bacterial transformants from each of the 27 PCR reactions were replica plated and screened by a combination of DNA sequencing and colony lift hybridization in order to identify the protein kinase from which each subcloned catalytic domain fragment was derived.
A total of 1450 bacterial transformants were analyzed by this approach. Of these, greater than 70% contained protein kinase cDNA inserts as determined by hybridization and sequencing. Analysis of these clones resulted in the identification of 33 tyrosine kinases and 8 serine/threonine kinases (Table 1 ). The 19 receptor tyrosine kinases and 14 cytoplasmic tyrosine kinases isolated accounted for all but 33 of the 1056 kinase-containing clones. The remaining clones were derived from 8 serine/threonine kinases, 7 of which were represented by a single clone each, including each of the novel kinases isolated in this screen. Approximately half of the 41 kinases were isolated more than once, and most of these were isolated from more than one tissue or cell line (Table 1 and data not shown). Eight tyrosine kinases, including Jak2, Fgfr1, EphA2, Met, Igf1r, Hck, Jak1, and Neu, accounted for 830 (79%) of all clones analyzed (Table 1) . Conversely, 18 kinases (44%) were represented by a single clone each, suggesting that further screening of cDNA libraries derived from these tissues and cell lines may yield additional kinases. The number of clones isolated for each kinase presumably reflects a combination of mRNA abundance and extent of homology to the oligonucleotide primers used in the amplification reaction.
Three novel protein kinases were identified in this screen, designated Bstk1, 2, and 3. Each of these kinases contains the amino acid motifs characteristic of serine/ threonine kinases ( Fig. 1 ). Bstk1 was isolated from a mammary epithelial cell line derived from a tumor that arose in an MMTV-neu transgenic mouse and is most closely related to the SNF1 family of serine/threonine kinases. A full-length cDNA encoding Bstk1 has subsequently been isolated (Gardner et al., 2000b) , as have partial cDNA sequences (Korobko et al., 1997) . Bstk2 and Bstk3 were each isolated from the mammary glands of mice undergoing early postlactational regression. Bstk2 exhibits highest homology to kinases recently identified in Saccharomyces cerevisiae and Arabidopsis thaliana and analysis of fulllength clones encoding this kinase indicates that it represents the first vertebrate member of a new family of mammalian protein kinases (Kurioka et al., 1998; Ligos et al., 1998; Stairs et al., 1998) . Bstk3 is most closely related to calcium/calmodulin-dependent protein kinase I, and full-length isoforms have subsequently been identified in the mouse and rat (Yokokura et al., 1997, and Gardner et al., 2000a) .
Expression of Protein Kinases in Mammary Epithelial Cell Lines
As a first step in investigating the range of expression patterns for the 41 protein kinases isolated in this screen, we determined kinase expression profiles in a panel of 18 murine mammary epithelial cell lines (Fig. 2) . These included 14 cell lines derived from independent tumors arising in transgenic mice expressing either the neu, c-myc, H-ras, or int-2 oncogenes under the control of the MMTV LTR, 1 cell line derived from the hyperplastic mammary epithelium of an MMTV-int-2 transgenic mouse, and 3 nontransformed, nontransgenic mammary epithelial cell lines ( Fig. 2) (Leder et al., 1986; Morrison and Leder, 1994; Muller et al., 1988 Muller et al., , 1990 Sinn et al., 1987) . Kinase expression was also investigated in NIH3T3 fibroblasts in order to identify those kinases that might be expressed in a mesenchymal-or epithelial-specific manner. All cell lines were grown under identical conditions and were harvested while actively proliferating.
Of the 41 kinases isolated in this screen, 25 were found to be ubiquitously expressed in the epithelial cell lines examined ( Fig. 2 and data not shown). Steady-state mRNA levels for 11 of these ubiquitously expressed kinases exhibited relatively little variation among cell lines. These include Tyk2, Neu, Ryk, Plk, Csk, Akt1, A-Raf, Prkmk3, and the insulin receptor. Steady-state mRNA levels for the remaining 14 ubiquitously expressed kinases varied considerably among cell lines. These include the receptor tyrosine kinases Egfr, Igf1R, Met, Tyro3, EphA2, EphA7/Hek11/Ehk3, and EphB3/Hek2, as well as the cytoplasmic tyrosine kinases Jak1, Jak2, c-Abl, c-Src, Lyn, and Tec and the serine/threonine kinase SLK (Fig. 2 and data not shown).
In contrast, mRNA expression of 11 of the kinases examined was detectable in only a subset of epithelial cell lines. These kinases range from those that are expressed within the majority of cell lines tested, such as Fgfr1, Fyn, Axl, and Mlk1, to kinases that are expressed in only a small number of these cell lines, such as Tyro10, c-Fes, c-Kit, and Flt3 (Fig. 2 and data not shown). Within this latter group of kinases, Ron, Srm, and Hck are expressed at detectable Note. Kinases are arranged by family and class. The number of clones isolated for each kinase is shown on the right. levels in only a single mammary epithelial cell line each (Fig. 2 and data not shown). Interestingly, both EphB3 and c-Kit are preferentially expressed in tumor cell lines derived from MMTV-neu and MMTV-Ha-ras transgenic animals compared to cell lines derived from MMTV-c-myc and MMTV-int-2 transgenic animals. Oncogene-associated patterns of expression have also been observed for Bstk1 and Bstk3 (Gardner et al., unpublished results) . Similar patterns of expression in this panel of cell lines have previously been reported for protein tyrosine phosphatase ⑀ and other molecules (Elson and Leder, 1995; Morrison and Leder, 1994) .
Additional patterns of expression that presumably reflect cell-type specificity were observed. For instance, Mlk1 is expressed in all cell lines except for NIH3T3 fibroblasts and FIG. 2. Protein kinase expression in murine breast cancer cell lines. Transformed cell lines were derived from mammary adenocarcinomas or mammary hyperplasias (HBI2) arising in transgenic animals expressing the int-2, c-myc, neu, or v-Ha-ras oncogenes in the mammary gland, as indicated. Northern hybridization analysis of 6 g of poly(A) ϩ RNA from actively growing murine cell lines hybridized with cDNA probes specific for each of the kinases indicated is shown. Origins of the cell lines from left to right are as follows: NIH3T3 fibroblast, nontransformed (Non-Tx) (NMuMG, HC11, and CL-S1), MMTV-int-2 (HBI2 and 1128), MMTV-c-myc (8Ma1a, MBp6, M1011, M158, and 16MB9a), MMTV-neu (SMF, NAF, NF639, NF11005, and NK-2), and MMTV-Ha-ras (AC816, AC711, and AC236).
for MBp6, the sole mammary cell line that does not express the epithelial marker cytokeratin 18. The resulting inference that Mlk1 expression is epithelial-specific was subsequently confirmed by in situ hybridization (Fig. 8 ). By comparison with Mlk1, Tyro10 exhibited an inverse pattern of expression with steady-state levels of mRNA detectable only in NIH3T3, MBp6, and the int-2-initiated tumor cell line, 1128, suggesting that this kinase is preferentially expressed in stromal compared to epithelial cells. This hypothesis was also confirmed by in situ hybridization ( Figs. 10E-10H ). Similarly, expression in mammary epithelial cell lines was detected neither for Tie1 nor Tie2, each of which has been shown to be expressed in an endothelialspecific manner, nor for MuSK, whose expression is restricted to muscle (Ganju et al., 1995; Partanen et al., 1992; Sato et al., 1993; Valenzuela et al., 1995b) .
Surprisingly, expression of the receptor tyrosine kinases EphB3/Hek2 and EphA7/Hek11/Ehk3 was demonstrated in all of the mammary epithelial cell lines examined, despite the fact that expression of these kinases has been reported to be restricted primarily to the central nervous system (Aasheim et al., 1997; Adams et al., 1999; Bergemann et al., 1998; Fox et al., 1995; Krull et al., 1997; Valenzuela et al., 1995a) . Similarly, despite previous reports that expression of each of the nonreceptor tyrosine kinases Lyn, Tec, and Hck is restricted primarily to cells of hematopoietic origin, Lyn and Tec expression was detected in all 18 mammary epithelial cell lines tested, and Hck expression was detected in 2 mammary tumor cell lines (Fig. 2 and data not shown) (Kluppel et al., 1997; Quintrell et al., 1987; Sato et al., 1994; Umemori et al., 1992; Yi et al., 1991; Ziegler et al., 1987) . Interestingly, Lyn has been shown to specifically bind and phosphorylate Tec in hematopoietic cells in vivo, suggesting that Tec is a downstream effector of Lyn (Mano et al., , 1996 . Our finding that Lyn and Tec are also coexpressed in mammary epithelial cells suggests that this signaling pathway may function in mammary epithelial cells as well as in cells of hematopoietic origin.
Expression of Protein Kinases during Postnatal Mammary Development
Since the expression of regulatory molecules is frequently controlled at the level of transcription, we analyzed the temporal pattern of expression during postnatal mammary development for each of the protein kinases isolated in this screen. Kinase expression was determined in mammary glands harvested from male FVB mice and from female mice at nine time points corresponding to developmental milestones encompassing puberty (2, 5, and 10 weeks of age), pregnancy (days 7, 14, and 20), lactation (day 9), and postlactational regression (days 2 and 7). Replicate Northern blots containing poly(A) ϩ mRNA from each of these developmental stages were hybridized with probes prepared from catalytic domain fragments corresponding to each kinase.
As an initial control, Northern blots were hybridized with probes for the genes encoding ␤-actin, Gapdh, and cytokeratin 18 (Fig. 3) . The resulting patterns were consis-tent with previous observations that steady-state levels of mRNA for many genes appear to decline during lactation and, to a lesser extent, late pregnancy and early postlactational regression (Marquis et al., 1995; Rajan et al., 1997) . Since the expression of ␤-actin, gapdh, and cytokeratin 18 does not decrease on a per-cell basis when assayed by in situ hybridization (J. Hartman, unpublished results), this phenomenon most likely results from a dilutional effect due to the extraordinary increase in milk protein gene expression that occurs during lactation. Expression levels for each kinase were therefore quantitated by phosphorimager analysis and normalized to ␤-actin in order to correct for these dilutional effects.
A wide range of developmental patterns of gene expression was observed for the kinases surveyed in this study.
FIG. 3. Expression of control genes during mammary gland development. Northern hybridization analysis of mRNA expression is shown for cytokeratin 18, Gapdh, and ␤-actin, during postnatal developmental of the murine mammary gland. 3 g of poly(A) ϩ RNA isolated from the mammary glands of FVB mice at the indicated time points was hybridized to 32 P-labeled cDNA probes for the genes indicated. The smear of poly(A) ϩ RNA beneath the 28S ribosomal RNA band is shown as a loading control. Note the apparent decrease in gene expression levels during lactation for all three genes, despite the similar amount of poly(A) ϩ present. Origins of the mammary developmental time points are as follows: adult male; nulliparous females at 2 weeks (prior to puberty), 5 weeks (during puberty), and 10 weeks (following puberty) of age; gravid females at day 7, day 14, and day 20 of pregnancy; day 9 of lactation; and day 2 and day 7 of postlactational regression.
Based on the assumption that kinases exhibiting distinctive patterns of regulation during particular stages of mammary development may be involved in regulating specific developmental events, we grouped these genes according to similarities in their developmental expression profiles. This approach revealed an ordered set of expression profiles that suggested the coordinated regulation of protein kinases acting at different stages of mammary development. While the observation that a particular kinase is expressed in a developmentally regulated manner does not prove that the kinase plays a role in development, the spatial and temporal patterns of expression for a gene often provide important clues to its biological function. Similarly, the identification of kinases with common developmental expression profiles may identify kinases whose developmental functions are related.
Kinase Expression during Ductal Morphogenesis
Prior to the onset of puberty at 2 weeks of age, the mammary glands of female FVB mice consist of a rudimentary epithelial tree originating from the nipple and penetrating a short distance into a mammary fat pad composed of fibroblasts and adipocytes. Following the onset of puberty at approximately 3 weeks of age, increased levels of ovarian steroids trigger the formation of club-shaped terminal end buds at the ends of growing mammary ducts. These are composed of highly proliferative, relatively undifferentiated epithelial cells that give rise to the differentiated cell types of the mammary tree, and the appearance of these structures marks the onset of the rapid cellular proliferation characteristic of ductal morphogenesis. By 5 weeks of age, over half of the mammary fat pad is filled with epithelial ducts as a consequence of ongoing ductal elongation and branching. The completion of ductal morphogenesis occurs at 10 weeks of age when most terminal end buds have reached the edge of the fat pad and have regressed.
Unlike many strains of mice in which males lack mammary glands, mammary glands are present in male FVB mice and can be studied. This represents one advantage of studying mammary development in this strain of mice. Accordingly, several protein kinases, including c-Abl, Met, Csk, hck, c-Src, Fgfr1, Axl, Jak1, Jak2, Tyro3, Mlk1, and Ctk, exhibited similar levels of expression in the mammary glands of adult male mice and 2-week-old female mice . Presumably, this reflects the fact that both adult males and prepubescent females have low levels of circulating 17␤-estradiol and possess only a rudimentary mammary epithelial tree. Conversely, levels of expression for FIG. 4. Expression of protein kinases during ductal morphogenesis. Northern hybridization analysis of Tie1 and Ron expression during postnatal development of the murine mammary gland is shown. 3 g of poly(A) ϩ RNA isolated from the mammary glands of FVB mice at the indicated time points was hybridized to 32 P-labeled cDNA probes for the genes indicated. Origins of the mammary developmental time points are as in Fig. 3 . Phosphorimager analysis of Northern blots is shown for Tie1 and Ron. Protein kinase expression was quantitated and normalized to ␤-actin expression to correct for dilutional effects due to large-scale increases in milk protein gene expression during late pregnancy and lactation. Expression levels normalized to ␤-actin are shown relative to adult virgin (10 wk).
Tie1, Ron, SLK, and Plk differed in the mammary glands of adult male and 2-week-old female mice, potentially reflecting different levels of androgens, different diets (e.g. chow versus milk), or other age-specific or gender-specific differences between these two groups of mice. Several protein kinases, including Ron, Met, c-Abl, Axl, Jak1, Tyro3, and Mlk1, exhibited an increase in expression in the mammary glands of nulliparous mice between 2 and 5 weeks of age concomitant with the onset of ductal morphogenesis (Figs.  4 -7) . This pattern may reflect increases in circulating steroid hormone levels, increases in cellular proliferation, or increases in epithelial cell content (as reflected by the expression pattern of cytokeratin 18), that occur at the onset of puberty or changes in diet that occur at weaning (Fig. 3) . Thus, similarities and differences in diet, hormonal environment, cellular proliferation, cellular differentiation, and epithelial content may account for changes in kinase expression patterns observed at different developmental stages.
The tyrosine kinases Tie1, Ron, and Srm each exhibited unique expression patterns with highest steady-state levels of mRNA occurring during the development of the virgin gland ( Fig. 4 and data not shown) . The endothelial-specific receptor tyrosine kinases Tie1 and Tie2 were each found to be expressed at highest levels just prior to the onset of puberty in 2-week-old female mice ( Fig. 4 and data not shown). A similar pattern of developmental expression was observed for the nonreceptor tyrosine kinase, Srm (data not shown). Little is currently known regarding the physiological state of the prepubescent mammary gland. However, since Tie1 and Tie2 are required for the normal growth and organization of blood vessels, as well as for establishing the structural integrity of the vascular endothelium (Sato et al., 1995) , this observation suggests the possibility that changes in endothelial cells or in the vasculature of the mammary gland may precede the rapid ductal growth that begins at puberty.
In contrast to Tie1 and Tie2, expression of the receptor tyrosine kinase Ron increases progressively during ductal morphogenesis, is downregulated at the onset of pregnancy, and remains low throughout the remainder of postnatal mammary development (Fig. 4) . Since the ligand for Ron, Macrophage-Stimulating Protein, is a motility factor that promotes integrin-dependent epithelial cell migration , it is plausible to hypothesize that Ron may contribute to the rapid epithelial migration characteristic of ductal morphogenesis. Consistent with this hypothesis, activation of Ron in epithelial cell lines results in enhanced proliferation, migration, and invasion through reconstituted basement membranes (Santoro et al., 1996; Tamagnone and Comoglio, 1997; Wang et al., 1996) . Moreover, Ron is overexpressed in a subset of human primary breast carcinomas (Maggiora et al., 1998) . Together, these observations suggest a potential role for Ron in epithelial invasion during both normal and neoplastic mammary development.
Kinase Expression during Pregnancy and Lactation
Early in pregnancy, alveolar epithelial cells proliferate rapidly to form alveolar buds in response to rising levels of estrogens and progesterone. Alveolar cell proliferation occurs primarily during the first half of pregnancy, whereas alveolar differentiation occurs in a graded and progressive manner throughout pregnancy. This culminates in the withdrawal of epithelial cells from the cell cycle late in pregnancy concomitant with their terminal differentiation. Lactation, the final stage of lobuloalveolar development, occurs following parturition in the hormonal setting of high prolactin levels and declining estrogen and progesterone levels. The marked cellular changes that occur in the mammary gland during pregnancy and lactation are reflected on a molecular level by the temporally ordered expression of different milk protein genes (Robinson et al., 1995) . Each of the members of this class of genes undergoes a maximal increase in expression at a characteristic time during pregnancy and can be classified as an early, intermediate, or late marker for mammary epithelial differentiation.
Similar to milk protein genes, clustering of protein kinases on the basis of similarities in their developmental expression patterns also yields an ordered temporal set of expression profiles throughout pregnancy and lactation (Figs. 5 and 6) . Consistent with the dramatic changes that take place in the mammary gland during these developmental stages, over half of all kinases examined were regulated during lobuloalveolar development. These were grouped into two sets based on whether kinases were upregulated or downregulated during pregnancy.
Seventeen kinases were found to be upregulated during pregnancy, and examination of their temporal expression profiles indicates that successive waves of kinase expression occur at each stage of lobuloalveolar development (Fig.  5 ). Ten kinases, including EphA7, SLK, c-Abl, Met, Lyn, c-Kit, and Egfr, exhibited maximal upregulation during early pregnancy. A smaller number of kinases exhibited maximal upregulation during the remainder of lobuloalveolar development, including mid-pregnancy (Hck) as well as late pregnancy and lactation (c-Akt1 and c-Fes).
Expression of the receptor tyrosine kinase EphA7 in tissues of adult mice has principally been described in the central nervous system. In this study, we detected EphA7 expression both in mammary epithelial cell lines and in the mammary gland, where it is maximally upregulated during early pregnancy. Interestingly, during fetal development EphA7 is expressed in bone marrow pro-B and pre-B cells, but not in more mature fetal B-lineage cells or in any B-lineage cells of the adult (Aasheim et al., 1997) . In light of the similarities between postnatal mammary development and the embryonic development of other organs, it is possible that EphA7 may play a lineage-specific or differentiation-dependent role in the mammary gland during early pregnancy.
The receptor tyrosine kinase Met has previously been implicated in mammary development by virtue of its ability to stimulate branching morphogenesis and lumen for-mation in mammary epithelial cells (Niemann et al., 1998; Tsarfaty et al., 1992) . In addition, some studies have suggested that c-Met is overexpressed in a subset of human breast cancers, and the mammary glands of transgenic mice expressing the tpr-met oncogene develop hyperplastic alveolar nodules and carcinomas (Jin et al., 1997; Liang et al., 1996) . Nevertheless, a role for Met in mammary development has not been directly demonstrated.
FIG. 5.
Expression of protein kinases upregulated during pregnancy. Northern hybridization analysis of protein kinase expression during postnatal development of the murine mammary gland is shown for a selection of kinases that are upregulated during pregnancy. 3 g of poly(A) ϩ RNA isolated from the mammary glands of FVB mice at the indicated time points was hybridized to 32 P-labeled cDNA probes for the genes indicated. Northern blots are arranged with kinases exhibiting upregulation early in pregnancy at the top and kinases exhibiting upregulation late in pregnancy at the bottom. Origins of the mammary developmental time points are as in Fig. 3 . Phosphorimager analyses of selected Northern blots are shown on the right. Expression levels normalized to ␤-actin are shown relative to adult virgin (10 wk).
Unlike other kinases analyzed in this study, both c-Akt1 and c-Fes were maximally upregulated in the mammary gland during lactation. Akt1 has recently been shown to provide survival signals in response to a variety of growth factors and cytokines, and the Akt pathway is suppressed by the PTEN tumor suppressor gene. The further finding that germ-line mutations in PTEN predispose women to breast cancer suggests that Akt1 may be a prosurvival signal in the mammary epithelium as well (Li et al., , 1998 Stambolic et al., 1998; Steck et al., 1997) . Consistent with this hypothesis, Akt1 is expressed at high levels in human breast cancer cell lines. Similarly, while c-Fes expression has not previously been reported in the mammary gland, this kinase has been implicated in the induction of terminal myeloid differentiation and in promoting the survival of differentiating myeloid cells (Ferrari et al., 1994; Manfredini et al., 1997; Yu et al., 1989) . The high levels of Akt1 and c-Fes expression observed in the mammary gland during lactation suggest that these kinases may play a role in propagating survival signals in terminally differentiated cells. As such, the rapid downregulation of Akt1 and c-Fes expression at parturition may contribute to FIG. 6. Expression of protein kinases downregulated during pregnancy. Northern hybridization analysis of protein kinase expression during postnatal development of the murine mammary gland is shown for a selection of kinases that are downregulated during pregnancy. 3 g of poly(A) ϩ RNA isolated from the mammary glands of FVB mice at the indicated time points was hybridized to 32 P-labeled cDNA probes for the genes indicated. Origins of the mammary developmental time points are as in Fig. 3 . Phosphorimager analyses of selected Northern blots are shown on the right. Expression levels normalized to ␤-actin are shown relative to adult virgin (10 wk).
the onset of large-scale apoptosis at day 2 of postlactational involution. Such a model is consistent with the hypothesis that terminally differentiated cells are dependent on survival signals from hormones and growth factors to prevent death (Wyllie et al., 1992) .
Ten protein kinases were found to be downregulated in the mammary gland during pregnancy. In most cases, no marked changes in expression were observed until day 14 of pregnancy. However, for each kinase downregulation persisted throughout late pregnancy, lactation, and early postlactational regression (Fig. 6 ). The function of most of the downregulated kinases in mammary development is unknown. The majority of downregulated tyrosine kinases are growth factor receptors. These include Fgfr1, Axl, and the insulin receptor, each of which appears to mediate mitogenic responses in mammary epithelial cells. Overexpression of Fgfr1 and of the insulin receptor has been described in subsets of human breast cancers (Adnane et al., 1991; Ugolini et al., 1999; Webster et al., 1996) . Conversely, downregulation of mitogenic growth factor pathways during mid-and late pregnancy may be required for the withdrawal of epithelial cells from the cell cycle that accompanies terminal differentiation. This hypothesis is consistent with the finding that downregulation of Fgfrmediated signaling is required for the terminal differentiation of myogenic cells during avian development (Itoh et al., 1996) .
Alternately, changes in the expression of some receptor tyrosine kinases, such as the insulin receptor, may reflect the marked metabolic changes that occur in mammary gland during pregnancy.
Kinase Expression during Postlactational Involution
Immediately following weaning, secretory alveoli rapidly involute as the majority of mammary epithelial cells die in the apoptotic process of postlactational regression or involution. Cell death begins within 2 days following weaning, and by day 7 of postlactational involution, intensive remodeling of the mammary epithelium, stroma, and extracellular matrix is well underway.
Three protein kinases identified in this screen were found to be upregulated in the involuting mammary gland (Fig. 7) . Expression of the receptor tyrosine kinase Tyro3 is dramatically upregulated in the mammary gland at day 2 of involution, yet returns to preregression levels by day 7. Since Tyro3 has been proposed to play a role in the growth and remodeling of the central nervous system, it is possible that it plays an analogous role in the mammary gland (Lai et al., 1994; Stitt et al., 1995) .
Like Tyro3, Mlk1 is also maximally upregulated in the mammary gland at day 2 of involution (Fig. 7) . The developmental expression profiles of Mlk1 and Tyro3 share additional similarities as each kinase undergoes a modest initial upregulation in the mammary glands of nulliparous mice between 2 and 5 weeks of age and is further upregulated at the onset of pregnancy.
The developmental pattern of Mlk1 expression was further investigated by in situ hybridization (Fig. 8 ). This revealed that Mlk1 is expressed in the mammary gland in an epithelial-specific manner, as was predicted based on the similarity of its expression pattern in cell lines to that of cytokeratin 18. During puberty, Mlk1 is preferentially ex- pressed in epithelial cells of terminal end buds compared to ducts (Fig. 8, cf. 8B and 8D ). This finding may explain the upregulation of Mlk1 observed in the mammary glands of 5-week-old mice. In situ hybridization further revealed that the modest upregulation of Mlk1 expression that occurs during pregnancy is due to preferential induction of Mlk1 expression in developing alveoli compared to ducts, and also confirmed the dramatic upregulation of this kinase in involuting alveoli at day 2 of regression. The preferential expression of Mlk1 in specific structures within the epithelial compartment, such as terminal end buds and developing alveoli, demonstrates that the expression of this kinase is regulated spatially as well as temporally during mammary development.
In contrast to Tyro3 and Mlk1, expression of the Cskrelated cytoplasmic tyrosine kinase Ctk remains low throughout virgin development and pregnancy (Fig. 7) . Induction of Ctk expression is initially observed during lactation, with maximal upregulation occurring at day 7 of involution. Ctk expression has previously been described only in the brain (Brinkley et al., 1995) . Together, the developmental patterns of expression observed for Tyro3, Mlk1, and Ctk suggest that these kinases may play a role in the dramatic changes that occur in the mammary gland during involution.
Proliferation-Dependent Patterns of Kinase Expression
An intriguing pattern of developmental expression was observed for the mammalian polo-like kinase, Plk. Plk expression is maximally upregulated in the mammary gland at day 7 of pregnancy, with a progressive decline in expression observed thereafter (Fig. 9 ). No expression was detected during lactation. Smaller increases in Plk expression were noted in the mammary glands of 5-week-old nulliparous animals. The observation that the upregulation of Plk expression coincides with peak alveolar proliferation rates during early pregnancy, as well as previous observations that Plk expression is cell cycle-regulated (Lee et al., 1995) , suggested that the developmental pattern of expression of this kinase reflects proliferative events in the mammary gland. This hypothesis is supported by the marked similarities in the expression profiles of Plk, cyclin A, and cyclin D1 (Fig. 9 ). As such, these findings strongly suggest that the temporal profile of Plk expression reflects increases in mitotic activity that occur in the mammary gland during puberty and early pregnancy. Consistent with this hypothesis, the developmental expression of Plk in the mammary gland is spatially restricted to proliferating cellular compartments, particularly in terminal end buds during puberty and alveolar buds during pregnancy (data not shown).
Spatial Regulation of Kinase Expression
In addition to the diverse temporal patterns of expression observed for the kinases analyzed in this study, diverse spatial patterns of expression were also observed. Similar to Mlk1 and Plk, the serine/threonine kinase SLK is upregulated in the mammary epithelium at day 7 of pregnancy (Figs. 5, 7-9, and 10A-10D, and data not shown). However, whereas Mlk1 and Plk are preferentially expressed in alveoli compared to ducts at this stage of development, SLK upregulation occurs in both ducts and alveoli. This observation suggests that upregulation of SLK expression may occur in response to signals that are distributed throughout FIG. 9. Expression of protein kinases as a function of proliferation. Northern hybridization analysis of protein kinase and cyclin expression during postnatal development of the murine mammary gland is shown. 3 g of poly(A) ϩ RNA isolated from the mammary glands of FVB mice at the indicated time points was hybridized to 32 P-labeled cDNA probes for the genes indicated. Origins of the mammary developmental time points are as in Fig. 3 . Phosphorimager analysis of the Northern blot for Plk is shown on the right. Expression levels normalized to ␤-actin are shown relative to adult virgin (10 wk).
the epithelium, rather than to changes specific to a subset of epithelial cells within a particular compartment.
Unlike the majority of kinases analyzed in this study, our initial finding that Tyro10 is preferentially expressed in cell lines that are negative for expression of the epithelial marker cytokeratin 18 (Fig. 2) . Within the mammary gland, Tyro10 is expressed in regions immediately surrounding epithelial structures ( Fig. 10E and 10F ) as well as in regions at the periphery of the mammary fat pad ( Fig. 10G and 10H) . Interestingly, Tyro10 expression is strikingly heterogeneous in stromal cells, suggesting that the expression of this kinase may be restricted to a specific stromal cell type.
DISCUSSION
We have isolated 33 tyrosine kinases and 8 serine/ threonine kinases that are expressed during the postnatal development of the murine mammary gland. Since transcription is one of the key steps at which gene expression is regulated, we chose to examine the mRNA expression of each of these kinases in a panel of transgenic mammary epithelial cell lines and in the mammary gland during multiple stages of development. Although protein kinases are typically regulated at the posttranslational level, the majority of kinases analyzed in this study were also found to be developmentally regulated at the mRNA level. Kinases were subsequently clustered into groups based on similarities in these expression patterns as a first step in drawing inferences about developmental processes in which they might be involved. In this manner, the panel of protein kinases identified in this study was used to produce a temporal map of developmental gene expression for the mammary gland.
While the temporal patterns of gene expression observed for the protein kinases surveyed in this study were diverse, application of a clustering approach revealed an ordered set of expression profiles in which successive waves of kinase expression occur during development. This finding suggests that a coordinated program of protein kinase expression exists that may play a role in regulating the cascade of events constituting mammary development.
A wide range of kinases was isolated in this study, including members of multiple receptor tyrosine kinase, cytoplasmic tyrosine kinase, and serine/threonine kinase subfamilies. A subset of the kinases that were identified in mammary gland samples was not expressed in the mammary epithelial cell lines tested, presumably as a result of their expression in a nonepithelial cell type. In contrast, virtually all of the kinases identified in mammary tumor cell lines were also found to be expressed in the mammary gland during development. This observation suggests that the expression of kinases detected in mammary epithelial cell lines is not merely a consequence of malignant transformation, nor of culture conditions, but rather suggests that these molecules may play a role in the normal physiology of the mammary gland. Of note, the kinase expression patterns observed in the panel of mammary epithelial cell lines tested were markedly heterogeneous, with dissimilar expression patterns observed even for kinases that displayed similar expression profiles during development. We conclude that kinase expression patterns in mammary gland samples and in epithelial cell lines reflect distinct aspects of mammary biology.
In recent cDNA microarray experiments in the yeast S. cerevisiae, more than 60% of characterized genes that were found to be regulated in a cell cycle-dependent manner were already known to have functions related to the cell cycle (Cho et al., 1998) . Thus, while the finding that expression of a particular kinase is developmentally regulated does not prove that the kinase plays a role in development, the spatial and temporal patterns of expression for a gene may provide important clues to its biological role. Kinases exhibiting distinctive patterns of regulation during mammary development may, in fact, be involved in controlling or mediating developmental events. Similarly, the identification of kinases that share developmental expression profiles may also identify kinases whose developmental functions are related.
The vast majority of protein kinases isolated in this screen currently have no recognized role in mammary development. Since poorly characterized genes whose expressions fluctuate in parallel may not only be regulated by parallel pathways, but also may function in parallel pathways, RNA expression patterns may provide a straightforward means of gaining insight into roles played in mammary development. As such, extrapolation may yield insights into the role in mammary development played by kinases whose functions have been elucidated in other tissues. Conversely, insight into the function of kinases lacking previously described roles in murine development may be gained by extrapolation from patterns of kinase expression during mammary development.
The expression of a number of kinases isolated in our study has previously been reported to be restricted to tissues other than the mammary gland. Such kinases include EphB3, EphA7, Ctk, Lyn, Hck, and Tec. Each of these kinases is also expressed in the mammary epithelial cell lines tested. Our observation that the majority of these kinases are developmentally regulated in the mammary gland suggests that these molecules have additional unrecognized functions. It will be of great interest to determine whether the functions of these kinases in mammary development are analogous to their functions in other tissues.
RT-PCR screens designed to identify protein kinases expressed in mammary carcinomas or in the mammary gland have previously been reported by three groups: Lehtola et al. isolated 10 protein kinases from the human breast cancer cell line MCF-7; Cance et al. isolated 25 protein kinases from a human breast carcinoma and from the human breast cancer cell line 600PEI; and Andres et al. isolated 24 protein kinases from murine mammary glands (Andres et al., 1995; Cance et al., 1993; Lehtola et al., 1992) . In total, these screens resulted in the identification of 43 protein kinases, 21 of which were also identified in the present study. In addition to these previously isolated kinases, our screen has resulted in the identification of an additional 20 kinases expressed in the mammary gland, bringing the total number of kinases identified in this manner to 63.
In aggregate, beyond providing clues to the regulation of different stages of postnatal mammary development by specific protein kinases, approaches similar to those taken here should prove useful in identifying sequences of events, as well as coherent regulatory patterns, in mammary development. Moreover, by analogy with hematopoiesis, certain kinases may be expressed in the mammary gland in a lineage-restricted manner and may thereby serve as useful markers for epithelial or stromal cell subtypes. As such, it is likely that the composite spatial and temporal pattern of kinase expression in the mammary gland at any given developmental stage can provide important information regarding its physiological state and should provide insight into the molecules that regulate different stages of postnatal mammary development. Ultimately, the finding that most kinases expressed in the mammary gland are developmentally regulated suggests that the array of kinases participating in the regulation of mammary development is considerably broader than currently appreciated.
